Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 2Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Motor Activity 3Colorectal Neoplasms 2Vomiting 1Urologic Neoplasms 1Urinary Incontinence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pain, Postoperative 1Ovarian Neoplasms 1Osteolysis 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nausea 1Multiple Myeloma 1Lung Neoplasms 1Liver Diseases 1Liver Cirrhosis 1Jaw Cysts 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 29Carboplatin 26durvalumab 21Specimen Handling 21Pemetrexed 17Cisplatin 16atezolizumab 15Paclitaxel 15Magnetic Resonance Spectroscopy 15Nivolumab 14osimertinib 12Radiosurgery 11Radiotherapy 10Immunoglobulin G 10Etoposide 10Disulfides 10Radiation 9Docetaxel 9Taxes 8Gemcitabine 8Biopsy 8Blood Specimen Collection 7Standard of Care 6Practice Guidelines as Topic 6Ipilimumab 6Surveys and Questionnaires 5Platinum 5Bevacizumab 5Ramucirumab 4Irinotecan 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lung Neoplasms × Control Groups × Clear all
NCT02991677 2024-08-06

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Baltimore VA Medical Center

Phase NA Active not recruiting
60 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Motor Activity, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡